Aeroports de Paris SA (0NP8)
London Exchange · UK · prices in EUR · close of 21 Oct 2026
Key indicators
| Last close | EUR 109.20 |
|---|---|
| 52-week range | 96.55 – 130.13 |
| Return, 1 month / 3 months | −2.2% / +5.2% |
| Return, 1 year / 3 years | −7.9% / +14.7% |
| Trend | Uptrend |
| RSI (14) | 53 |
| Volatility (1 year) | 32.4% |
| Worst drawdown (1 year) | -23.9% |
| Average daily value traded | 0.51M EUR |
| Dividend yield | 2.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Aeroports de Paris operates the main airports serving Paris, including Charles de Gaulle and Orly, together with other regional French airports. It provides aeronautical services to airlines and passengers, runs terminal retail and car parking, and develops property around its sites. Its customers include airlines, travellers, retailers and commercial partners. The company is based in France and is majority owned by the French state.
On this site Aeroports de Paris SA appears as a stock on the London Exchange (UK), code 0NP8, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Aeroports de Paris SA (0NP8) trades on the London Exchange in UK. It last closed at EUR 109.20 on 21 October 2026.
Its price-based Market X-Ray is 51 out of 100 (a fair price profile), ranking 1,998 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.9% and over the last three months it rose 5.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 0.5% | ||
| From 52-week high | -15.0% | ||
| Momentum | 52 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 5.2% | ||
| 6-month return | 2.4% | ||
| 12-month return, skipping the last month | -5.9% | ||
| Stability (higher is calmer) | 60 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 32.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.9% | ||
| Liquidity | 46 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.51M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 40 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.7% | ||
| Years with dividends | 4 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +3.6% |
|---|---|
| 1 month | −2.2% |
| 3 months | +5.2% |
| 6 months | +2.4% |
| 1 year | −7.9% |
| 3 years | +14.7% |
| 5 years | +6.1% |
Signals
| 50-day / 200-day average | 108.72 / 108.66 |
|---|---|
| Golden / death cross (60 days) | Golden, 53 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.45 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jun 2026 | EUR 3.0000 |
| 3 Jun 2025 | EUR 3.0000 |
| 10 Jun 2024 | EUR 3.8200 |
| 5 Jun 2023 | EUR 3.1300 |
| 6 Dec 2019 | EUR 0.7000 |
| 7 Jun 2019 | EUR 3.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.